Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.’s Transaction with Neurocrine is Fair to Public Shareholders
Go back to Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.’s Transaction with Neurocrine is Fair to Public Shareholders| (NASDAQ: SLNO) | Delayed: 53.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.01 | 52 Week High | $ | |||
| Open | $53.01 | 52 Week Low | $ | |||
| Day High | $53.01 | P/E | N/A | |||
| Day Low | $53.01 | EPS | $ | |||
| Volume | 118,016 | |||||
